⌘K
Loading ticker…
As of 2026-08-24, TriSalus Life Sciences, Inc. Common Stock (TLSI) has a 3-month relative strength percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 57. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.7%, relative volume 0.44×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
TLSI is in a stage 1 base, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 11.6% / 6.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
TLSI is held by 9 ETFs as of May 2026. Top owner: VTWO at 0.00% weight, $488K notional. Top 3 carry $571K.
Held by 16 ETFs · $10M across latest filings · largest weight 0.02% (IWC).
Top 9 by value, from SEC N-PORT-P filings dated May 2026.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $4K |
| — |
| UWM | 0.00% | $4K | — |
| HDG | 0.00% | $89 | — |
| RB | 0.00% | $24 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TLSI Jan avg: -6.61% median: 2.00% win: 67% σ: 19.38% n: 3 2023-08-14 → 2026-07-31 | TLSI Feb avg: 6.69% median: 5.53% win: 100% σ: 5.55% n: 3 2023-08-14 → 2026-07-31 | TLSI Mar avg: -7.64% median: -4.17% win: 33% σ: 11.96% n: 3 2023-08-14 → 2026-07-31 | TLSI Apr avg: -1.19% median: -4.51% win: 33% σ: 8.06% n: 3 2023-08-14 → 2026-07-31 | TLSI May avg: -15.56% median: -21.07% win: 0% σ: 11.33% n: 3 2023-08-14 → 2026-07-31 | TLSI Jun avg: 6.51% median: 9.00% win: 67% σ: 28.25% n: 3 2023-08-14 → 2026-07-31 | TLSI Jul avg: -6.45% median: -0.22% win: 33% σ: 13.91% n: 3 2023-08-14 → 2026-07-31 | TLSI Aug avg: -10.05% median: -7.90% win: 33% σ: 34.59% n: 3 2023-08-14 → 2026-07-31 (current) | TLSI Sep avg: -14.86% median: -12.19% win: 0% σ: 5.76% n: 3 2023-08-14 → 2026-07-31 | TLSI Oct avg: -9.32% median: -13.88% win: 33% σ: 9.81% n: 3 2023-08-14 → 2026-07-31 | TLSI Nov avg: 17.61% median: 14.86% win: 67% σ: 26.06% n: 3 2023-08-14 → 2026-07-31 | TLSI Dec avg: 40.91% median: 9.87% win: 100% σ: 61.06% n: 3 2023-08-14 → 2026-07-31 |